Others: please purchase the materials or upgrade to standard/corporate members.
Jun 25, 2015 saw the official release of the draft of the revised China New Chemical Substance Notification Guidance after more than 1 year of deliberation. The development of the guidance is a sub-project of the national critical projects for chemical pollution control, managed by the Department of Pollution Prevention and Control of the MEP. The overall regulatory framework of China NCSN will not change, however ambiguities in the previous regulatory framework will be clarified through the revision of the Guidance, focusing on the applicable scope, management policy, data requirements and waiving, notification procedures, requirements of risk assessment report and post-notification requirements. This webinar looks closely at the draft revision of China NCSN Guidance, and will provide an indepth interpretation of the important updates.
- Review of China NCSN Guidance Revision Process
- Interpretation of Important Updates in Draft Revision of China NCSN Guidance
- Potential Changes Based on Industry’s Demands
Mr. Atlans Dale
Master in chemistry
Senior Regulatory Consultant from REACH24H Consulting Group
Mr. Atlans Dale is a recognized expert extremely experienced in China new chemical substance notification and Japan CSCL. He is a core member of REACH24H's new chemical substance notification Team and has extensive experience in handling more than one hundred China NCSN-related regulatory projects. In addition, he regularly runs regulatory training courses for global chemical companies.
To have a better chance of your questions being addressed during the webinar, please send them to firstname.lastname@example.org.
|15 July 2015||10:00-11:00 am||Chinese||Concluded, Materials Available|
|22 July 2015||14:00-15:00 pm||Janpan|
- All registrants can join the webinar for free
- Video, PPT slides and Q&A document are accessible for all registrants in 5 working days after the webinar
If you have any question about this webinar, please contact us.
Tel: +86(0)571 8609 4444